Literature DB >> 3583416

The spermatocytic seminoma: views on pathogenesis.

J Müller, N E Skakkebaek, M C Parkinson.   

Abstract

The spermatocytic seminoma has clinical and histological characteristics which differ from those of other germ cell tumours of the testis. Classical seminomas and teratomas are believed to originate from intratubular carcinoma-in-situ (CIS), which is almost invariably found adjacent to these neoplasms. In addition, DNA analysis of these tumours and the surrounding CIS has shown both to have an aneuploid distribution. In order to throw light on the origin of the spermatocytic seminoma, we have examined the testicular tissue adjacent to fifteen spermatocytic seminomas for the presence of CIS and assessed the DNA content of the tumour cells densitometrically. In twelve specimens seminiferous tubules were present adjacent to the tumour, and in none of these cases was CIS seen. Nuclear DNA measurements were possible in eleven tumours and in five cases the distribution was diploid, in three cases tetraploid, and only in three cases aneuploid. Therefore, we suggest that the spermatocytic seminoma has a different cell of origin from that of other germ cell tumours of the testis.

Entities:  

Mesh:

Year:  1987        PMID: 3583416     DOI: 10.1111/j.1365-2605.1987.tb00176.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  12 in total

1.  Proceedings of the 2017 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Famke Aeffner; Dinesh S Bangari; Torrie A Crabbs; Stacey Fossey; Shayne C Gad; Wanda M Haschek; Jessica S Hoane; Kyathanahalli Janardhan; Ramesh C Kovi; Gail Pearse; Lyn M Wancket; Erin M Quist
Journal:  Toxicol Pathol       Date:  2017-11-07       Impact factor: 1.902

Review 2.  Poor efficacy of BEP polychemotherapy in metastatic spermatocytic seminoma.

Authors:  Thomas Horn; Stephan Schulz; Tobias Maurer; Jürgen E Gschwend; Hubert R Kübler
Journal:  Med Oncol       Date:  2010-11-18       Impact factor: 3.064

Review 3.  [Diagnostic problems in testicular tumours in consultant pathology : A practical guide].

Authors:  Felix Bremmer; Alexander Fichtner; Annika Richter; Stefan Schweyer
Journal:  Pathologie (Heidelb)       Date:  2022-09-07

4.  Immunophenotyping of Rabbit Testicular Germ and Sertoli Cells Across Maturational Stages.

Authors:  B Banco; G Grilli; C Giudice; A Tomas Marques; S Cotti Cometti; G Visigalli; V Grieco
Journal:  J Histochem Cytochem       Date:  2016-09-30       Impact factor: 2.479

5.  Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: pathogenetic relevance.

Authors:  E Rajpert-De Meyts; M Kvist; N E Skakkebaek
Journal:  Virchows Arch       Date:  1996-06       Impact factor: 4.064

6.  Spermatocytic seminoma: a 21 years' retrospective study in a tertiary care hospital in Pakistan.

Authors:  Saroona Haroon; Muhammad Usman Tariq; Saira Fatima; Naila Kayani
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

7.  Selfish spermatogonial selection: evidence from an immunohistochemical screen in testes of elderly men.

Authors:  Jasmine Lim; Geoffrey J Maher; Gareth D H Turner; Wioleta Dudka-Ruszkowska; Stephen Taylor; Ewa Rajpert-De Meyts; Anne Goriely; Andrew O M Wilkie
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

8.  OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia.

Authors:  Jasmine Lim; Anne Goriely; Gareth Dh Turner; Katherine A Ewen; Grete Krag Jacobsen; Niels Graem; Andrew Om Wilkie; Ewa Rajpert-De Meyts
Journal:  J Pathol       Date:  2011-06-27       Impact factor: 7.996

9.  A 20-year retrospective study of histopathologic patterns of gonadal germ cell tumors in males in the University of Benin Teaching Hospital.

Authors:  Odokuma Emmanuel Igho
Journal:  Niger Med J       Date:  2015 Nov-Dec

10.  Human testicular germ cell tumours express inhibin subunits, activin receptors and follistatin mRNAs.

Authors:  R H van Schaik; C D Wierikx; L H Looijenga; J W Oosterhuis; F H de Jong
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.